B. Kongkathip et al. / Tetrahedron 72 (2016) 3296e3304
3303
4.12.2. Benzyl-2-O-isopentylidene-3-hydroxy-5-
a
-
D
-lyxofura noside
100 MHz) d: 137.3,136.7, 128.5,128.4,128.3,128.1, 127.8, 127.7, 127.6,
(19).8 From 8 (0.10 g, 0.32 mmol); colorless oil (0.04 g, 40% for
127.4, 126.8, 103.9, 82.5, 79.2, 73.0, 71.7, 69.4; HRMS (ESIþ) m/z
[MþNa]þ, calcd for C19H22NaO5: 353.1359, found: 353.1375.
Method A and 0.08 g, 75% for Method B); Rf (40% EtOAc/hexane)
0.32; [
a]
25 þ67.2 (c¼0.77, CHCl3); (lit. [
a
]
25 þ67.24 (c¼0.77, CHCl3));
D
D
FTIR (neat), ymax, 3434, 1101, 1021 cmꢀ1; 1H NMR (CDCl3, 400 MHz)
4.12.6. Benzyl-2-O-isopentylidene-3-hydroxy-5,6-dihydroxy-a-D-
d
: 7.32e7.20 (m, 5H, aromatic), 4.99 (d, J¼1.3 Hz, 1H, H-1), 4.67 (d,
lyxofuranoside (24). As described in general Method A; started
from 6 (0.10 g, 0.29 mmol); colorless oil (0.05 g, 52%); Rf (70%
J¼11.8 Hz, 1H, eOCH2Ph), 4.42 (d, J¼11.8 Hz, 1H, eOCH2Ph), 4.43
(ddd, J¼5.6, 7.0, 5.6 Hz, 1H, H-3), 4.10 (ddd, J¼4.0, 5.7, 2.8 Hz, 1H, H-
4), 3.87 (dd, J¼1.3, 5.4 Hz, 1H, H-2), 3.81e3.80 (m, 2H, H-5), 3.28 (qt,
J¼5.8 Hz, 1H, H-7), 3.08 (d, J¼7.1 Hz, 1H, eOH), 2.62 (br s, 1H, eOH),
1.51, 1.40 (m, 4H, H-8, H-9), 0.82, 0.79 (2ꢂ t, J¼7.4 Hz, 2ꢂ 3H, H-10,
EtOAc/hexane) 0.25; [
a
]
D
25 þ57.9 (c¼0.64, CHCl3); FTIR (neat),
ymax,
: 7.33e7.26 (m,
3434, 1101, 1021 cm-1; 1H NMR (CDCl3, 400 MHz)
d
5H, aromatic), 5.05 (d, J¼2.2 Hz, 1H, H-1), 4.70 (d, J¼11.8 Hz, 1H,
eOCH2Ph), 4.49 (d, J¼11.8 Hz, 1H, eOCH2Ph), 4.43 (m, 1H, H-3),
4.03e3.97 (m, 3H, H-2, H-4, H-5), 3.82 (dd, J¼2.7, 11.5 Hz, 1H, H-6),
3.67 (dd, J¼5.5, 11.5 Hz, 1H, H-6), 3.40 (br s, 1H, OH), 3.34 (qt,
J¼5.8 Hz, 1H, H-7), 1.57, 1.47 (m, 4H, H-8, H-9), 0.88, 0.85 (2ꢂ t,
H-11); 13C NMR (CDCl3, 100 MHz)
d: 137.4, 128.3, 127.8, 127.7, 104.5,
83.1, 81.1, 79.3, 71.6, 69.4, 61.5, 25.9, 25.7, 9.4, 9.3; HRMS (ESIþ) m/z
[MþNa]þ, calcd for C17H26NaO5: 333.1672, found: 333.1680.
J¼7.4 Hz, 2ꢂ 3H, H-10, H-11); 13C NMR (CDCl3, 100 MHz)
d: 137.4,
4.12.3. Benzyl-2-hydroxy-3-O-isopentylidene-5-
(20). From 8 (0.10 g, 0.32 mmol); colorless oil (0.02 g, 15% for
Method A); Rf (40% EtOAc/hexane) 0.25; [
CHCl3); FTIR (neat), ymax, 3434, 1101, 1021 cmꢀ1D
a-
D-lyxofura noside
128.3, 127.9, 127.8, 127.6, 105.5, 83.2, 89.6, 79.5, 71.1, 70.1, 69.7, 64.0,
26.0, 25.7, 9.4, 9.3; HRMS (ESIþ) m/z [MþNa]þ, calcd for
C18H28NaO6: 363.1789, found: 363.1806.
25
a
]
ꢀ79.4 (c¼1.27,
;
1H NMR (CDCl3,
400 MHz)
d
: 7.32e7.20 (m, 5H, aromatic), 4.97 (d, J¼4.24 Hz, 1H, H-
4.12.7. Benzyl-2-O-isopentylidene-3-hydroxy-5-O-benzyl-6-
1), 4.73 (d, J¼11.8 Hz, 1H, eOCH2Ph), 4.51 (d, J¼11.8 Hz, 1H,
eOCH2Ph), 4.23 (m, 1H, H-4), 4.10 (ddd, J¼5.64, 5.74, 5.52 Hz,1H, H-
3), 3.84 (dd, J¼4.24, 5.5 Hz, 1H, H-2), 3.82e3.77 (m, 2H, H-5), 3.29
(qt, J¼5.8 Hz, 1H, H-7), 3.05 (d, J¼7.4 Hz, 1H, eOH), 2.35 (br s, 1H,
eOH),1.54e1.46 (m, 4H, H-8, H-9), 0.86, 0.83 (2ꢂ t, J¼7.4 Hz, 2ꢂ 3H,
hydroxy-a-
D-mannofuranoside (25) and benzyl-2-hydroxy-3-O-iso-
pentylidene-5-O-benzyl-6-hydroxy-
a-D-mannofuranoside (26). As
described in general Method A; started from 18 (0.20 g, 0.47 mmol);
purification by flash column chromatography on silica gel eluting
with EtOAc:hexane, 1:4 afforded the product as a colorless oil
(0.10 g), 53% as two isomers (25:26¼3:2); Rf (70% EtOAc/hexane)
0.25; FTIR (neat), ymax, 3417, 3031, 2964, 2934, 1497, 1454,1209 cmꢀ1
H-10, H-11); 13C NMR (CDCl3, 100 MHz)
d 137.2, 128.2, 127.9, 127.6,
99.7, 82.7, 81.2, 77.7, 70.2, 69.3, 62.2, 25.9, 25.8, 9.3; HRMS (ESIþ) m/
z [MþNa]þ, calcd for C17H26NaO5: 333.1672, found: 333.1680.
Compound 25: 1H NMR (400 MHz, CDCl3)
d: 7.37e7.27 (m, 10H,
aromatic), 5.05 (s, 1H, H-1), 4.73 (d, J¼11.4 Hz, 1H, CH2Ph), 4.69 (d,
J¼11.8 Hz, 1H, CH2Ph), 4.61 (d, J¼11.4 Hz, 1H, CH2Ph), 4.50 (d,
J¼11.8 Hz, 1H, CH2Ph), 4.48e4.44 (m, 1H, H-3), 4.33 (dd, J¼7.3,
4.1 Hz, 1H, H-2), 4.05 (d, J¼4.9 Hz, 1H, H-4), 3.99e3.91 (m, 1H, H-5),
3.91e3.78 (m, 2H, 2ꢂ H-6) 3.38e3.31 (p, J¼5.9 Hz,1H, H-7), 2.50 (br
s, 2H, OH) 1.60e1.51 (m, 4H, H-8, H-9), 0.91e0.86 (t, J¼7.5 Hz, 3H,
H-10), 0.87e0.82 (t, J¼7.5 Hz, 3H, H-11); 13C NMR (CDCl3, 100 MHz)
4.12.4. Benzyl-2-O-isopentylidene-3-hydroxy-5-O-acetyl-
ofuranoside (21) and benzyl-2-hydroxy-3-O-isopentyli-dene-5-O-
acetyl- -lyxofuranoside (22). As described in general Method A;
started from benzyl 2,3-O-isopentylidene-5-O-acetyl- -lyxofur-
a-D-lyx-
a-D
a-D
anoside (0.05 g, 0.14 mmol), the residue was purified by flash col-
umn chromatography on silica gel eluting with EtOAc:hexane,
10:90 to give a 3:1 mixture of 21 and 22 (0.03 g, 60%) as a colorless
oil; Rf (20% EtOAc/hexane) 0.15; FTIR (neat), ymax, 3435, 3031, 2972,
d
: 137.7, 137.6, 137.5, 128.5, 128.4, 128.0, 127.9, 127.8, 106.6, 82.5,
79.6, 78.6, 73.3, 72.0, 69.4, 60.8, 25.8, 24.8, 9.5, 9.0; HRMS (ESIþ) m/z
[MþNa]þ, calcd for C25H34NaO6: 453.2248, found: 453.2256.
1742, 1738 cmꢀ1
Compound 21: 1H NMR (CDCl3, 400 MHz)
.
d: 7.34e7.26 (m, 5H,
Compound 26: 1H NMR (400 MHz, CDCl3)
d: 7.41e7.25 (m, 10H,
aromatic), 5.08 (d, J¼1.3 Hz, 1H, H-1), 4.70 (d, J¼11.8 Hz, 1H,
eOCH2Ph), 4.37 (m, 1H, H-2), 4.48 (d, J¼11.8 Hz, 1H, eOCH2Ph), 4.63
(m, 1H, H-3), 4.25e4.23 (m, 1H, H-5), 4.15e4.12 (m, 1H, H-5),
4.06e4.07 (m, 1H, H-4), 3.28 (qt, J¼5.8 Hz, 1H, H-7), 2.94 (br s, 1H,
OH), 2.07 (s, 3H, eC(O)CH3), 1.56e1.49 (m, 4H, H-8, H-9), 0.90, 0.86
(2ꢂ t, J¼7.4 Hz, 2ꢂ 3H, H-10, H-11).
aromatic), 5.08 (d, J¼2.6 Hz,1H, H-1), 4.77 (d, J¼11.4 Hz,1H, CH2Ph),
4.72 (d, J¼12.0 Hz, 1H, CH2Ph), 4.69 (d, J¼11.4 Hz, 1H, CH2Ph), 4.52
(d, J¼12.0 Hz, 1H, CH2Ph), 4.35 (dd, J¼5.1, 3.4 Hz, 1H, H-3), 4.15 (dd,
J¼7.8, 3.3 Hz, 1H, H-2), 4.04 (dd, J¼5.2, 2.6 Hz, 1H, H-4), 3.99e3.93
(m, 1H, H-5), 3.86 (dd, J¼11.7, 4.5 Hz, 1H, H-6), 3.72 (dd, J¼11.7,
4.2 Hz, 1H, H-6), 3.38 (p, J¼5.9 Hz, 1H, H-7), 2.42 (br s, 2H, OH)
1.62e1.47 (m, 4H, H-8, H-9), 0.91 (t, J¼7.5 Hz, 3H, H-10), 0.87 (t,
Compound 22: 1H NMR (CDCl3, 400 MHz)
d: 7.34e7.26 (m, 5H,
aromatic), 5.08 (d, J¼4.24 Hz, 1H, H-1), 4.75 (d, J¼12.4 Hz, 1H,
eOCH2Ph), 4.50 (d, J¼12.4 Hz,1H, eOCH2Ph), 4.47 (m,1H, H-3), 4.39
(d, J¼2.8 Hz, 1H, H-2), 4.34e4.32 (m, 1H, H-5), 4.25e4.23 (m, 1H, H-
5), 4.16e4.21 (m,1H, H-4), 3.31 (qt, J¼5.8 Hz,1H, H-7), 2.94 (br s,1H,
eOH), 2.07 (s, 3H, eC(O)CH3), 1.56e1.49 (m, 4H, H-8, H-9), 0.88,
0.85 (2ꢂ t, J¼7.4 Hz, 2ꢂ 3H, H-10, H-11).
J¼7.5 Hz, 3H, H-11); 13C NMR (CDCl3,100 MHz)
d: 138.3,137.5,128.4,
128.3, 127.9, 127.8, 127.7, 105.9, 83.1, 82.9, 79.5, 72.7, 70.6, 70.0, 69.4,
62.1, 25.8, 9.4, 9.3; HRMS (ESIþ) m/z [MþNa]þ, calcd for
C25H34NaO6: 453.2248, found: 453.2258.
Acknowledgements
Compound 21þ22: 13C NMR (CDCl3, 100 MHz)
d: 170.6, 170.4,
137.4,137.3,128.2,127.7,127.6,126.9,105.8, 81.9, 83.2, 78.2, 76.4, 76.2,
70.4, 69.1, 64.0, 63.1, 25.8, 25.7, 25.6, 25.2, 20.7, 9.2, 9.1; HRMS (ESIþ)
m/z [MþNa]þ, calcd for C19H28NaO6:375.1783, found: 375.1789.
N.C. is a Ph.D. student under the Royal Golden Jubilee Program of
the Thailand Research Fund (TRF). We are grateful for financial
support from the Thailand Research Fund and Kasetsart University
through the Royal Golden Jubilee Program. Financial support from
the Center of Excellence for Innovation in Chemistry (PERCH-CIC),
Commission on Higher Education, Ministry of Education and
Kasetsart University Research and Development Institute (KURDI)
are also gratefully acknowledged.
4.12.5. Benzyl-2-O-benzyl-3-hydroxy-5-a-D-lyxofuranoside (23). As
described in general Method A; started from 15 endo/exo (0.10 g,
0.30 mmol); colorless oil (0.08 g, 75%); Rf (20% EtOAc/hexane) 0.12;
25
[
a]
þ80.3 (c¼2.46, MeOH); FTIR (neat), ymax, 3431, 3088, 3063,
D
2929, 1496, 1454, 1024 cmꢀ1 1H NMR (400 MHz, CDCl3)
; d:
7.42e7.26 (m, 10H, aromatic), 5.16 (s, 1H, H-1), 4.74 (d, J¼11.8 Hz,
1H, CH2Ph), 4.66 (s, 2H, CH2Ph), 4.63e4.53 (m, 1H, H-3), 4.49 (d,
J¼11.8 Hz, 1H, CH2Ph), 4.18 (d, J¼4.6 Hz, 1H, H-2), 4.01 (d, J¼4.9 Hz,
1H, H-4), 3.97e3.80 (m, 2H, H-5), 2.84 (s, 2H, OH); 13C NMR (CDCl3,
Supplementary data
Supplementary data (1H and 13C NMR spectra for all new and
important known compounds) associated with this article can be